Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Mechanism of Action of Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study

NCT05200962 is registered in ClinicalTrials.gov with The National Brain Mapping Laboratory (NBML) as lead sponsor.

NCT NCT05200962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Mechanism of Action of Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study
Lead sponsor
The National Brain Mapping Laboratory (NBML)
Phase
Phase 1
Overall status
Unknown status
Start date
February 1, 2022
Completion date
August 1, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, schizophrenia